PSMA-guided ablation for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a targeted treatment for prostate cancer using PSMA imaging to guide ablation (removal) of the tumor. It may help men with early-stage, localized cancer that hasn't spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 50 years
- Your tumor is small and hasn't spread (stage T2b or lower)
- Your PSA level is less than 15
- Your biopsy shows a specific type of prostate cancer (Gleason grade group 2 or 3) on one side only
- You are able to lie flat for 30 minutes for a PET scan
- You have no history of hormone therapy or radiation for prostate cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET/MR scan to help doctors aim stereotactic radiation more precisely for certain higher-risk or unfavorable intermediate prostate cancers. It studies whether this targeted approach can safely treat the prostate (and specific areas needing extra treatment) without spreading to the body.
This trial tests if a special PET scan using PSMA-1007 can find prostate cancer spread in men who have just been diagnosed with high-risk prostate cancer and plan to have surgery. The scan may help doctors better understand the cancer before removing the prostate and lymph nodes.
This early-phase study tests a precise, targeted radiation treatment for prostate cancer, using a special PET scan to help plan exactly where to treat. It may help reduce the amount of radiation to surrounding tissues while treating the cancer.
This Phase 3 study checks whether a PSMA PET/CT scan (using a special tracer) can help doctors make better decisions for people with prostate cancer after treatment, based on PSA blood test changes. It may help identify whether cancer has spread or how to plan next steps.
This study allows people with prostate cancer to get a special PET scan that finds cancer cells. The scan helps doctors plan the best treatment. You may qualify if your PSA is rising or you have high-risk prostate cancer.
This trial uses a special scan (PSMA-PET) to find where prostate cancer has returned after surgery. Then doctors give a lower dose of radiation only to that area, which may reduce side effects. It is for men whose PSA level is rising after prostate removal.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.